SUMMARY ANSWER: About 200 genes are differentially expressed in the caput HEE cells after AR activation; the AR transcriptional network is tissue-specific and may be mediated in part by distinct AR co-factors including CAAT-enhancer binding protein beta (CEBPB) and runt-related transcription factor 1 (RUNX1).
Introduction
The epididymis is a tightly coiled tubular structure that forms a major part of the ducts through which sperm pass on their way from the testis to fertilize an oocyte. The luminal environment of the human epididymis is critical for normal sperm maturation (reviewed in Cornwall, 2009) . Epithelial cells lining the duct tightly regulate the ionic concentration, pH and protein composition of the luminal fluid. The maintenance of this highly defined and complex environment relies on the coordinated expression of many genes encoding cell structural proteins, ion channels and transporters, and secreted proteins (Zhang et al., 2006; Dube et al., 2007; Thimon et al., 2007; Browne et al., 2016b) . The transcriptional networks that integrate gene expression in the human epididymis epithelium are not yet fully defined. Among transcription factors (TFs) that are already identified as important regulators of epididymal luminal environment and sperm maturation in rodents are Reproductive homeobox X-linked 5 (Rhox5) (MacLean et al., 2012) , Ladybird-like homeobox gene 2 (Lbx2) (Moisan et al., 2008) and Sonic hedgehog (Shh) (Turner et al., 2006) . We recently identified hepatocyte nuclear factor 1 beta (HNF1β) as a regulator of genes involved in human epididymis epithelial (HEE) transport of water, phosphate and bicarbonate (Browne et al., 2016a) . The potential importance of HNF1β in HEE function was identified first by mapping open chromatin in caput HEE cells, and then by searching for over-represented TF binding motifs in these regions. Sites of open chromatin are suggestive of active cis-regulatory elements (Bischof et al., 2013; Browne et al., 2014b) . The enrichment of the androgen receptor (AR) motif in open chromatin regions that are selective to caput HEE cells also suggests a potential role for AR in the biology of this epithelium (Browne et al., 2014b) .
The importance of androgens and AR in the epididymis was established many years ago (Gloyna and Wilson, 1969; Blaquier et al., 1972; Robaire et al., 1977; Cohen et al., 1981) (reviewed in Robaire and Hamzeh, 2011) . AR protein is detected in all regions of the epididymis and in most of epididymal cell types (Sar et al., 1990; Zhou et al., 2002; Yamashita, 2004) . Transcriptional profiling of the epididymis in orchidectomized mice treated with high doses of dihydrotesterone (DHT) was reported (Chauvin and Griswold, 2004; Snyder et al., 2009) . Similarly a list of DHT-upregulated and -downregulated genes were documented after orchidectomy in rats (Hamzeh and Robaire, 2010) . A direct role for AR in normal epididymal function was demonstrated in knockout mouse models. A caput epididymal epithelium-specific AR knockout mouse showed abnormal epididymis morphology and impaired epithelial cell function and sperm transit (O'Hara et al., 2011) . Similar phenotypes were seen in a mouse with targeted inactivation of AR in the proximal epididymis (Krutskikh et al., 2011) . Thus most data on the role of AR in the epididymis derive from rodent models, in which the epididymis structure and function is notably different from human. Here we use primary adult HEE cells (Leir et al., 2015) to identify direct transcriptional targets of AR by chromatin immunoprecipitation followed by deep sequencing (ChIP-seq). We focus on the caput region of the epididymis since transcriptome profiling of HEE cells revealed that AR is most abundant in this region (Browne et al., 2016b) , which is also most relevant to the process of epididymal sperm maturation (Cornwall, 2009) . We show the impact of AR activation by synthetic androgens in HEE cells by RNA-seq and identify direct targets of AR by ChIP-seq. We also identify potential co-factors contributing to epididymis specific AR binding and find that these are different from those seen in the prostate epithelium. Our data reveal an AR-mediated transcriptional network, which is critical for normal epididymis function and sperm maturation.
Materials and Methods

Cell culture and immunofluorescence
Human epididymis tissue was obtained with Institutional Review Board approval from patients undergoing inguinal radical orchiectomy for a clinical diagnosis of testicular cancer. None of the epididymides had extension of the testicular cancer. Adult human epididymis epithelial (HEE) cells (caput) were established as described previously (Leir et al., 2015) , and grown in CMRL 1066 medium (containing 15% fetal calf serum, 2 mM L-glutamine, 1 μg/ml hydrocortisone, 0.2 U/ml insulin, and 10 -10 M cholera toxin (CT)). For experiments on androgen receptor (AR)-mediated pathways, cultures were grown in phenol red-free CMRL 1066 medium containing 15% charcoal stripped FCS without the other supplements described above for at least three days prior to treatment with 1 nM methyltrienolone (R1881; PerkinElmer NLP0050) for 12-16 h. Immunofluorescence detection of AR and TJP1/ZO-1 in HEE monolayers exposed to R1881 or control (ethanol) used standard protocols and the following reagents: Anti-AR (Santa Cruz Biotechnology #sc-816), anti-ZO-1 (Invitrogen #40-2200), Alexa Fluor ® 488
AffiniPure Goat Anti-Rabbit IgG (Jackson ImmunoResearch # 111-545-003) and FITC-Conjugated rabbit anti-mouse IgG (Dako #F0313).
Reverse transcription quantitative PCR
Total RNA was extracted from cells with TRIzol (Life Technologies (LT)) following the manufacturers protocols. RT-qPCR was performed by standard protocols. Briefly, cDNA was synthesized by using a TaqMan Reverse Transcription reagents kit (Applied Biosystems) with random hexamers, and qPCR experiments were carried out with SYBR Green master mixes. The sequences of the primer pairs specific for each target gene and the reaction conditions are listed in Supplementary Table SII .
RNA-seq
Total RNA was prepared from four replicates of control (ethanol) or R1881-treated cells. RNA quality was confirmed by Nanodrop measurement of OD 260/280 and 260/230 ratios and Bioanalyzer profiles. RNA-seq libraries were prepared from 2 μg of total RNA using the TruSeq RNA Sample Preparation Kit v2 per the manufacturer's Low-Throughput protocol (Illumina). The libraries were sequenced on Illumina HiSeq4000 machines. Data were analyzed using TopHat and Cufflinks (Trapnell et al., 2012) . All data are deposited at GEO: GSE109063.
ChIP-seq
ChIP-seq experiments for AR, CEBPB and RUNX1 were performed in two biological replicates (donors) after ethanol or R1881 treatment by standard protocols (Fossum et al., 2014) . Chromatin was prepared from caput HEE cells as described previously (Browne et al., 2014a) . For the immunoprecipitation, 10 μg of AR [Santa Cruz Biotechnology (SCB) sc-815x], CEBPB (sc150x) or RUNX1 (Abcam, ab23980) antibodies and~2 × 10 7 cells were used, and libraries were prepared as described previously (Fossum et al., 2014) . Libraries were sequenced on Illumina HiSeq2500 or HiSeq4000 machines. FASTQ files were aligned to the hg19 version of the human genome using Bowtie (Langmead et al., 2009) and ChIP-seq peaks were identified using HOMER (Heinz et al., 2010) with a false discovery rate (FDR) of 0.1%. ChIPseq data from both replicates were subjected to IDR analysis and only peaks with high confidence (0.1% threshold) were selected for downstream analysis (Fossum et al., 2017) . The ChIP-seq datasets are available on GEO (GSE109063). Identification of transcription factor motifs in the data set and peak annotation based on the nearest gene were also performed using HOMER.
ChIP-qPCR
Antibodies were as described for the ChIP-seq experiments above. Chromatin was prepared and ChIP was performed as for ChIP-seq. qPCR was performed by standard protocols (Browne et al., 2016a) .
siRNA-mediated depletion of CEBPB and RUNX1
HEE cells at 40-50% confluence were transfected with 40 nM siRNA (Ambion, purchased from ThermoFisher Scientific) as follows: a nontargeting control (Neg Con #1, #4390843), CEBPB (#4392420-s2891), RUNX1, (#4392420-s229352) using Lipofectamine RNAiMax reagent (LT) in OptiMEM. After 24 h, media was replaced with phenol red-free CMRL 1066 medium containing 15% charcoal stripped FCS without the supplements for 24 h prior to treatment with 1 nM R1881 as above for 18 h. Then RNA was extracted using TRIzol ® (LT), whole cell lysate was isolated using NET Buffer (Leir et al., 2015) , and chromatin was prepared as for ChIP as described above (Browne et al., 2014a) . Western blots were probed with antibodies specific for AR (sc-816), CEBPB (sc-7962) and RUNX1 (sc-365644) (from Santa Cruz) and beta-tubulin (T4026, Sigma).
Statistical analysis
GraphPad Prism 6 software was used to analyze statistical differences between experimental groups using students t-test and values of P < 0.05 were considered significant. Data are expressed as mean ± Standard Error of the Mean (SEM).
Results
Genome-wide AR occupancy defined by ChIP-seq
Using an antibody that detects AR specifically, we mapped the genomic locations bound by AR with or without agonist in primary caput HEE cells. The cells were first hormone starved for 72 h before treatment with either 1 nM R1881 (a potent synthetic AR agonist) or vehicle control (ethanol), using a protocol that was optimized in our previous work (Leir et al., 2015) . Figure 1 shows relocation of AR into the nucleus after R1881 treatment compared to control (ethanol) and confirms that this protocol has no impact on the structural integrity of the epithelial cell layer, as show by tight junction protein 1 (ZO-1) distribution. After 16 h, cells were harvested for the ChIP-seq experiment. Two independent biological replicates were performed with cells from two individual donors. The sequencing data were aligned by Bowtie 1.0.0 and analyzed with Homer software and IDR (Irreproducible Discovery Rate) analysis was applied to the data in order to identify AR peaks of high confidence.
With an IDR threshold of 0.1%, 8748 AR peaks were identified in the R1881 treated cells and only 61 peaks were identified for the vehicle control treated cells. The results indicate that ligand binding of AR is required for its DNA binding activity, and confirmed the specificity of the antibody used for the ChIP experiment. The distribution of AR peaks in the HEE cell genome is shown in Fig. 2A , where 48.9% and 45.6% of peaks are located in intergenic and intronic regions, respectively. The remaining 5.5% of peaks are found in promoters (-1 kb to +100 b with respect to the transcription start sites of genes) or other genomic regions (such as untranslated regions (UTRs) and exons). An example of the ChIP-seq signal enrichment is shown in Fig. 2B at the FKBP5 gene locus, which is a well-characterized AR target in prostate cells (Magee et al., 2006) . Specific AR peaks are identified in intron 5 of FKBP5, which is a previously characterized enhancer, as well as at several sites close to the gene promoter (Fig. 1B) . Of note, the intron 5 and promoter sites also correspond to regions of open chromatin that we documented in primary HEE cells using DNase-seq (GEO:GSE74709, Yang et al., 2016) . These data confirmed specific binding of AR to known targets in the presence of AR ligand. This, combined with the strong correlation in the genome-wide AR binding profile between the two replicates (by Irreproducible Discovery Rate (IDR) analysis), generated confidence in the AR peaks identified by our ChIP-seq experiments.
De-novo motif analysis of the 8748 AR ChIP-seq peaks was next performed to determine the enrichment of TF binding motifs. The AR binding motif was the most significantly enriched (P = 1e -1834 ) and 44% of all peaks contained this motif, providing further support for the robustness of these ChIP-seq datasets (Fig. 2C) . Amongst other TF motifs, which are significantly enriched in the ChIP-seq peaks are those of Jun-AP1, CEBP (CAAT-enhancer binding protein), TEAD (TEA domain transcription factor), and RUNX (Runt-related transcription factor), which thus are potential candidates to function as co-factors of AR.
The epididymis specific AR transcriptional regulatory network
Although AR has an important role in regulating gene expression in multiple tissue types, studies to date on AR in the male reproductive system have largely focused on the prostate gland. Here we characterized the AR cistrome in primary caput HEE cells enabling a comparison between AR functions in the male reproductive ducts and previous data from normal prostate tissue or cells and prostate cancer. To identify epididymis-specific AR-associated pathways, we compared the epididymis AR peaks from our data and publicly available AR cistrome data from LNCaP prostate cancer cells (Yu et al., 2010) or normal prostate tissue (Pomerantz et al., 2015) . This comparison revealed a distinct pattern of AR binding in epididymis cells compared to the prostate samples (Fig. 3) . Among the 8748 peaks of epididymal AR occupancy, only 19.6% and 21.0% overlap with peaks identified in LNCaP and normal prostate, respectively. In contrast, 38.3% of the normal prostate AR peaks overlap with LNCaP whereas only 7.8% overlap with the epididymis. Details of the overlapping peaks among the three datasets are shown in Fig. 3A .
The motif recognized by AR in epididymis and prostate is very similar, hence it seemed probable that different co-factors interact with AR in the two tissues, resulting in the tissue specific AR binding. To test this hypothesis, de-novo motif analysis was performed for the AR ChIP-seq datasets from epididymis, normal prostate and prostate cancer (LNCaP). The top five enriched motifs from the three datasets are shown in Fig. 3B , where the two prostate datasets show very similar motifs enriched in the sequences surrounding AR peaks. These motifs include FOXA1 (Forkhead box A1), HOXB13 (Homeobox B13), and NF1 (Nuclear Factor 1), which were all reported previously (Yu et al., 2010; Sharma et al., 2013; Jin et al., 2014; Pomerantz et al., 2015) . FOXA1 and HOXB13 were also shown to interact with AR and play important roles in prostate cancer progression (Robinson et al., 2014 , Pomerantz et al., 2015 Kron et al., 2017) . However, in the caput HEE cells FOXA1, HOXB13 and NF1 are not among the enriched motifs, with CEBP, TEAD and RUNX motifs evident instead. The relative enrichment of AR, CEBP, and RUNX motifs around AR peaks was also characterized in the three cell types. The results showed enrichment of the AR motif in all cell types but specific enrichment of both CEBP and RUNX motifs only in the caput HEE cells (Fig. 3C) .
Potential cooperation between AR and CEBPB or RUNX1
Our RNA-seq data generated previously from cells of the three anatomical regions of the epididymis (caput/head, corpus/body and cauda/tail) (Browne et al., 2016b) , were used to predict the specific transcription factors binding to the CEBP and RUNX motifs. CEBP beta and RUNX1 are the most abundant isoforms expressed in the caput HEE cells so these were chosen for further study although other family members are also present (FPKM values are CEBPA: 2.64, CEBPB: 54.14, CEBPG: 21.39 and CEBPE: 0.01; RUNX1 :20.44, RUNX2: 7.75 and RUNX3: 0.008; Browne et al., 2016b) . ChIP-seq experiments were performed to map the occupancy of CEBPB and RUNX1 in the caput HEE cell genome with or without R1881 treatment. Experimental procedures and data analysis were carried out as described earlier for the AR ChIP-seq. The ChIP-seq signals of AR, CEBPB, and RUNX1 around the Adhesion G Protein-Coupled receptor G2 (ADGRG2) gene (also known as GPR64), a potential AR target Immunofluorescence of androgen receptor (AR) (A-D) in primary caput HEE cells treated ethanol (control) or R1881 for 16 h. R1881 treatment induced AR relocation from the cytoplasm to the nucleus (white arrows). 6-Diamino-2-phenylindole (DAPI) was used for nuclear counterstaining. Maintenance of structural integrity of the HEE cell layers after R1881 treatment was shown by ZO-1 staining (E-H; white arrows). Size bar = 50 μM.
in the epididymis, are shown in Fig. 4A . ADGRG2 encodes an epididymis-selective transmembrane receptor that is pivotal in epididymis function (Patat et al., 2016) and which we know is expressed in Caput HEE cells (Browne et al., 2016b and Supplementary Table SI) . R1881-induced occupancy by AR of a site 5' to the ADGRG2 promoter (Fig. 4A , black arrow) coincides with a peak of constitutive binding of CEBPB, that is not influenced by the AR agonist. Further, a peak of CEBPB and RUNX1 occupancy in the first intron of ADGRG2 lacks AR and is unaffected by R1881 treatment (Fig. 4A, gray arrow) . To examine whether AR activation affects binding of these co-factors genomewide, ChIP-seq signal intensities of AR, CEBPB, and RUNX1 with either control or androgen treatment were compared in a 1 kb region centered around AR peaks (Fig. 4B) . As expected, the AR ChIP-seq signal is strongly enriched in the middle of the region with R1881 treatment but not with the vehicle control. In contrast, both CEBPB and RUNX1 showed almost identical binding profiles around AR peaks with or without androgen treatment. These results suggest that the binding of CEBPB and RUNX1 is independent of AR activation and that these co-factors probably function upstream of AR. The analysis shown in Fig. 4B also revealed that CEBPB and RUNX1 share very few common co-localizations with AR peaks, suggesting that there is little cross-talk between the two factors, although both may cooperate with AR individually. Moreover, the co-localization of AR and the cofactors was observed to occur at relatively weak AR binding sites, with almost no overlap between AR and CEBPB or RUNX1 at sites where AR signals are the strongest. Since little difference in CEBPB and RUNX1 binding was observed with or without androgen treatment, we intersected the three datasets all under androgen treated conditions. The numbers of overlapping peaks are shown in Fig. 4C . In agreement with Fig. 4B , a considerable portion of the AR peaks were also bound by CEBPB (30.9%) or RUNX1 (26.1%). Conversely, only a small percentage of CEBPB (5.3%) or RUNX1 (16.9%) peaks were occupied by AR, which likely reflects the more general functions of these factors in comparison to AR.
Dependency of AR binding on its co-factors in HEE cells
To investigate further the interactions of CEBPB and RUNX1 at R1881-dependent AR binding sites, we focused on a single locus, the well-characterized FKBP5 locus (Fig. 2B) . Since the bioinformatics analysis above predicted that CEBPB and RUNX1 likely functioned upstream of AR binding, we next used specific siRNAs to deplete each factor separately and in combination and then performed ChIP with an antibody specific for AR after vehicle or R1881 exposure of the HEE cells. AR occupancy was assayed at the FKBP5 promoter and a site -3.5 kb 5' to the promoter (Fig. 2B , black and gray arrows, respectively) by ChIPqPCR (Fig. 5) . As expected R1881 increased the abundance of AR (Fig. 5Ai/ii) , but had no impact on CEPBB and very little impact RUNX1 protein levels. siRNA-mediated depletion of CEBPB and RUNX1 was effective though of note depletion of CEBPB also somewhat reduced RUNX1 levels, suggesting that the latter might be a transcriptional target of CEBPB. Stimulation of HEE cells with R1881 significantly increased occupancy of AR at both the FKBP5 promoter (Fig. 5B) ( Fig. 5C ). ChIP after CEBPB depletion significantly reduced AR occupancy at the promoter though the reduction was not significant at -3.5 kb. This suggests that AR binding at the FKBP5 promoter is dependent on CEBPB potentially as a co-activator. Combined depletion of CEBP and RUNX1 also significantly reduced R1881 activated AR binding at the promoter. In contrast, depletion of RUNX1 alone slightly increased androgen-activated AR occupancy at the promoter and the -3.5 kb site, though in neither case was the change statistically significant. Also of note was the significant increase in basal AR occupancy at the -3.5 kb element upon combined depletion of CEBPB and RUNX1 without R1881 treatment, suggesting that this distal cis-element might be subject to different regulatory mechanisms than the gene promoter.
The AR transcriptional network in caput HEE cells
We previously documented the transcriptome of HEE cells from the caput, corpus and cauda regions of the epididymis (Browne et al., 2016b) . Here we build on these data to examine the alterations in gene expression effected by androgen-activation of AR in caput HEE cells. Data from four biological replicas were combined to identify 204 significantly differentially expressed genes (DEGs) (Supplementary Table SI ).
Intersection of genes that were differentially regulated after R1881 treatment with loci with an AR ChIP-seq peak within 20 kb, identified those of particular interest as direct AR targets. These included Jagged 1 (JAG1, a Notch signaling ligand), Sonic Hedgehog (SHH) and Left-right determination factor (LEFTY1), all AR targets in prostate cancer cells (LaTulippe et al., 2002; Bolton et al., 2007) . G-protein coupled receptor 64 (GPR64) (Adhesion G Protein-Coupled Receptor G2, ADGRG2) is an epididymis GPR that was not previously known to be AR regulated, though our data above showed R1881-dependent occupancy of AR at the locus. Validation of these AR targets was performed by RT-qPCR (Fig. 6 ). GPR64 and LEFTY1 are both significantly upregulated by R1881 treatment while JAG1 shows minor repression, consistent with the RNA-seq data. Of note only eight DEGs in HEE cells overlap with loci reported to be androgen-regulated in prostate cancer cells (Supplementary Table SI , marked in red type), reinforcing our earlier observations suggesting that the AR transcriptional program in the epididymis is distinct from that of prostate cells.
Discussion
Relatively little is known about the transcriptional networks controlling the differentiated functions of the human male reproductive ducts. Here we report genome-wide occupancy data for the androgen receptor, one of the key transcription factors in primary human caput epididymis cells. To date, most studies on human AR transcriptional regulation focus on prostate cancer or normal prostate tissue. The functions of AR in the human epididymis are poorly understood in large part due to the lack of experimental materials. Although AR lossof function models provided important insights into the roles of AR in development and function of the rodent male genital tract, there are profound interspecies differences. The establishment of robust cell cultures from adult human epididymis (Leir et al., 2015) enabled us to interrogate the AR transcriptional network in human cells. By comparing our AR ChIP-seq data in caput HEE cells to the published data generated in prostate cells, we found that AR distribution varies substantially in the two cell types. The distinct AR binding profiles in epididymis and prostate cells suggests that AR may regulate genes involved in epididymis specific functions, especially those involved in regulating epididymal luminal environment. For example, we note occupancy of AR in an epididymis-selective region of open chromatin 5' to the promoter of the cystic fibrosis transmembrane conductance regulator gene (CFTR). CFTR encodes an apical membrane chloride ion channel that has a pivotal role in establishing the luminal fluid of the epididymis (Pollard et al., 1991; Leir et al., 2015) . Of note, loss of function mutations in CFTR are associated with defects in epididymis and vas deferens that result in the infertility of males with CF. Despite the tissue selective binding profile of AR, it responds to the agonist similarly and recognizes the same motif in both prostate and epididymis cells. To search for mechanisms underlying the cell-specificity of AR binding, we first looked at potential divergence in its co-factors in the two tissues. Several studies previously showed reprograming of AR binding by co-factors during prostate oncogenesis with STAT family members, MYC, E1F and FOXA1 likely having key roles in different tumor types (Sharma et al., 2013; Jin et al., 2014 motifs unique to epididymis cells, including CEBP, TEAD, and RUNX motifs. CEBPB belongs to the CCAAT/enhancer binding proteins (CEBPs) family. CEBPs all have a highly conserved DNA-binding domain, the basic region-leucine zipper motif (bZIP) and are well studied in liver gene regulation and energy metabolism (Roesler, 2001 ).
RUNX1 is one of the RUNX family members which are mainly involved in cellular differentiation and cell cycle progression (Durst and Hiebert, 2004; de Bruijn and Dzierzak, 2017; Deltcheva and Nimmo, 2017) and can function both as repressors or activators. The bestcharacterized roles of RUNX1 are in hematopoiesis and leukemia Statistics by t-test. *P < 0.05, **P < 0.01, ***P < 0.001 comparing to NC siRNA, Veh or # P < 0.05, ## P < 0.01, ### P < 0.001 comparing to NC siRNA, R1881. (B, C)
ChIP-qPCR with an AR antibody to determine occupancy of AR at (B) the FKBP5 promoter or (C) the -3.5 kb element, as shown by arrows in Fig. 1C . Key CE = CEBPB, RU = RUNX1, Veh = vehicle. For both panels the black bars show IgG controls and the open bars show AR occupancy. Enrichment is shown as fold over IgG. Data from donor HEE cultures, statistics by t-test, *P < 0.05, **P < 0.01, ***P < 0.001.
(reviewed in Ito et al., 2015) . However, the function of these factors in the epididymis is largely unknown. The comparison of ChIP-seq data for AR and the co-factors in HEE cells revealed several interesting findings. Firstly, the binding profiles of both CEBPB and RUNX1 are not affected by androgen treatment (Fig. 4B) . In the absence of androgens, very little AR binding is evident whereas the co-factors show equivalent occupancy with vehicle or after R1881 treatment. Thus CEBPB and RUNX1 binding is independent of AR occupancy, indicating that these co-factors may function upstream of AR. Another feature of the ChIP-seq results is that AR peaks often overlap with CEBPB or RUNX1 peaks individually but rarely coincide with both jointly. This suggests that CEBPB and RUNX1 may cooperate with AR independently and may not interact with each other at AR binding sites. The data also showed that localization of AR and CEBPB or RUNX1 occurred preferentially in relatively weak AR binding sites. It is possible that binding of AR at these locations is dependent on the co-factors to stabilize the interactions. Our observation on the loss of AR occupancy at two sites in the FKBP5 locus upon siRNA-mediated depletion of CEBPB would support this hypothesis. However, the potential role of RUNX1 remains to be elucidated.
ADGRG2 (formerly named HE6 or GPR64) belongs to the family of adhesion-GPCRs (G protein-coupled receptors) and is a full orphan receptor with no synthetic or endogenous ligands known (reviewed in Paavola and Hall, 2012) . Abundant transcripts of this gene were found in epididymis by differential screening of a human epididymal cDNA library (Osterhoff et al., 1997) and it was later found to have a key role in sperm maturation. Hemizygous mutant male mice with a disrupted ADGRG2 gene (ADGRG2 is X-linked) had severely reduced fertility primarily due to dysregulation of fluid reabsorption, preventing spermatozoa from migrating through the epididymis (Davies et al., 2004) . Subsequently several epididymis-specific genes were found to be downregulated in microarray analysis of the same mouse model (Davies et al., 2007) . Many of these repressed genes encode secretory and membrane proteins which may contribute to control of the epididymal luminal environment. ADGRG2 functions have also been investigated in breast cancer where it is involved in the adhesion and migration of certain breast cancer cells through non-canonical NFkB pathways (Peeters et al., 2015) . Here we show by RNA-seq that the ADGRG2 gene is upregulated in response to R1881 in HEE cells and validated this by RT-qPCR. In androgen-treated cells, four peaks of AR occupancy were present within 100 kb upstream of ADGRG2 gene, including one that is adjacent to the promoter (Fig. 4A) , which is also occupied by CEBPB. In combination, our data support a model in which AR modulates the normal function of human caput epididymis cells, including secretion, fluid transport, and cell adhesion through direct transcriptional activation of the ADGRG2 gene. The specific downstream pathways that are regulated by ADGRG2 in HEE cells warrant further investigation.
The current AR ChIP-seq data combined with RNA-seq after androgen stimulation in HEE cells provides evidence for an ARregulated transcriptional network in the human caput epididymis epithelium. However, additional work is required to identify and confirm other direct targets of AR and to enable the discovery of relevant biological pathways regulated by this factor in normal epididymis function. Further studies are also required to understand the mechanism whereby AR exerts such different functions in epididymis and prostate. Though different co-factors in the epididymis were identified in the current study, our understanding of how they interact and contribute to AR specific binding is incomplete.
Supplementary data
Supplementary data are available at Molecular Human Reproduction Online. Figure 6 Androgen regulation of genes in HEE cells. HEE cells were exposed to R1881 (1 nM for 16 h), RNA was extracted and RT-qPCR was performed using standard protocols and gene-specific primers. Black bars, vehicle treated; gray bars, R1881-treated. Data are shown as expression level relative to the vehicle control (set to 1) for each gene. n = 4 for each assay. Statistical analysis by two-tailed t-test: *P < 0.05.
